Secondly, MET amplification, mutation and other genes like NTRK1 and PTEN, which may coexist with EGFR gene in EGFR-TKIs treatment-naive samples, were not detected in current study for lack of sufficient tumor tissues. This evidence concerns the gene MET and neoplasm.